Integrum Past Earnings Performance
Past criteria checks 0/6
Integrum has been growing earnings at an average annual rate of 34.8%, while the Medical Equipment industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 30.2% per year.
Key information
34.8%
Earnings growth rate
42.6%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 30.2% |
| Return on equity | -3.0% |
| Net Margin | -4.2% |
| Last Earnings Update | 31 Jan 2024 |
Recent past performance updates
Recent updates
We Think Integrum (STO:INTEG B) Can Easily Afford To Drive Business Growth
May 03
Does Integrum (STO:INTEG B) Deserve A Spot On Your Watchlist?
Sep 20Integrum's (STO:INTEG B) Earnings Aren't As Good As They Appear
Dec 09Introducing Integrum (STO:INTEG B), The Stock That Soared 873% In The Last Year
Mar 18Is Integrum's (STO:INTEG B) Share Price Gain Of 242% Well Earned?
Dec 03
Revenue & Expenses BreakdownBeta
How Integrum makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jan 24 | 100 | -4 | 86 | 0 |
| 31 Oct 23 | 87 | -17 | 85 | 0 |
| 31 Jul 23 | 80 | -6 | 88 | 0 |
| 30 Apr 23 | 78 | -16 | 85 | 0 |
| 31 Jan 23 | 81 | -7 | 84 | 0 |
| 31 Oct 22 | 76 | 7 | 75 | 0 |
| 31 Jul 22 | 66 | 19 | 65 | 0 |
| 30 Apr 22 | 61 | 21 | 55 | 0 |
| 31 Jan 22 | 52 | 16 | 46 | 0 |
| 31 Oct 21 | 49 | 16 | 41 | 0 |
| 31 Jul 21 | 49 | 2 | 39 | 0 |
| 30 Apr 21 | 44 | -2 | 35 | 0 |
| 31 Jan 21 | 39 | -4 | 35 | 0 |
| 31 Oct 20 | 35 | -9 | 36 | 0 |
| 31 Jul 20 | 31 | -14 | 36 | 0 |
| 30 Apr 20 | 28 | -16 | 38 | 0 |
| 31 Jan 20 | 23 | -20 | 41 | 0 |
| 31 Oct 19 | 21 | -24 | 44 | 0 |
| 31 Jul 19 | 25 | -24 | 45 | 0 |
| 30 Apr 19 | 26 | -25 | 46 | 0 |
| 31 Jan 19 | 26 | -23 | 44 | 0 |
| 31 Oct 18 | 22 | -23 | 40 | 0 |
| 31 Jul 18 | 17 | -23 | 37 | 0 |
| 30 Apr 18 | 19 | -18 | 34 | 0 |
| 31 Jan 18 | 20 | -17 | 33 | 0 |
| 31 Oct 17 | 24 | -10 | 31 | 0 |
| 31 Jul 17 | 22 | -9 | 28 | 0 |
| 30 Apr 17 | 23 | -6 | 26 | 0 |
| 31 Jan 17 | 24 | 0 | 21 | 0 |
| 30 Apr 16 | 18 | 0 | 16 | 0 |
| 30 Apr 15 | 17 | 0 | 14 | 0 |
| 30 Apr 14 | 19 | 2 | 12 | 0 |
Quality Earnings: INTEG B is currently unprofitable.
Growing Profit Margin: INTEG B is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INTEG B is unprofitable, but has reduced losses over the past 5 years at a rate of 34.8% per year.
Accelerating Growth: Unable to compare INTEG B's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: INTEG B is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (59.4%).
Return on Equity
High ROE: INTEG B has a negative Return on Equity (-2.99%), as it is currently unprofitable.